The early immunological response to acute ischemic stroke: Differential gene expression in subpopulations of mononuclear cells

Neuroscience

Volumn 160, Issue 2, 2009, Pages 394-401

  Kassner, S S ^a   Kollmar, R ^b   Bonaterra, G A ^c   Hildebrandt, W ^d   Schwab, S ^b   Kinscherf, R ^c  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c Centre for Biomedicine and Medical Technology Mannheim CBTM   (Germany)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

lymphocytes; lymphopenia; macrophages; monocytes; oxLDL; PBMC

Indexed keywords

CASPASE 3; CD14 ANTIGEN; CD19 ANTIGEN; CD3 ANTIGEN; CD38 ANTIGEN; CD40 ANTIGEN; CD68 ANTIGEN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; OXIDIZED LOW DENSITY LIPOPROTEIN; TUMOR NECROSIS FACTOR ALPHA;

AGED; ARTICLE; CELL DIFFERENTIATION; CELL SUBPOPULATION; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; IMMUNE RESPONSE; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; APOPTOSIS REGULATORY PROTEINS; BRAIN ISCHEMIA; CASE-CONTROL STUDIES; CELL COUNT; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; LEUKOCYTES, MONONUCLEAR; LIPOPROTEINS, LDL; LYMPHOCYTE SUBSETS; MALE; MATCHED-PAIR ANALYSIS; MIDDLE AGED; MONOCYTES; REFERENCE VALUES; STATISTICS, NONPARAMETRIC; STROKE;

EID: 64449083246     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2009.02.050     Document Type: Article

References (59)

1. Berard M., Casamayor-Palleja M., Billian G., Bella C., Mondiere P., and Defrance T. Activation sensitizes human memory B cells to B-cell receptor-induced apoptosis. Immunology 98 (1999) 47-54
2. Berard M., Mondiere P., Casamayor-Palleja M., Hennino A., Bella C., and Defrance T. Mitochondria connects the antigen receptor to effector caspases during B cell receptor-induced apoptosis in normal human B cells. J Immunol 163 (1999) 4655-4662
3. Beschorner R., Nguyen T.D., Gozalan F., Pedal I., Mattern R., Schluesener H.J., Meyermann R., and Schwab J.M. CD14 expression by activated parenchymal microglia/macrophages and infiltrating monocytes following human traumatic brain injury. Acta Neuropathol 103 (2002) 541-549
4. + cells in ischemic brain lesions. J Neuroimmunol 126 (2002) 107-115
5. Bonaterra G.A., Hildebrandt W., Bodens A., Sauer R., Dugi K.A., Deigner H.P., Turcanu D., Heinle H., Dröge W., Metz J., and Kinscherf R. Increased gene expression of scavenger receptors and proinflammatory markers in peripheral blood mononuclear cells of hyperlipidemic males. J Mol Med 85 (2007) 181-190
6. Bonaterra G.A., Hildebrandt W., Bodens A., Sauer R., Dugi K.A., Schlittenhardt D., Deigner H.P., Dröge W., Metz J., and Kinscherf R. Increased cyclooxygenase-2 expression in peripheral blood mononuclear cells of smokers and hyperlipidemic subjects. Free Radic Biol Med 38 (2005) 235-242
7. Braun J.S., Prass K., Dirnagl U., Meisel A., and Meisel C. Protection from brain damage and bacterial infection in murine stroke by the novel caspase-inhibitor Q-VD-OPH. Exp Neurol 206 (2007) 183-191
8. Chamorro A., Urra X., and Planas A.M. Infection after acute ischemic stroke: a manifestation of brain-induced immunodepression. Stroke 38 (2007) 1097-1103
9. Chatterjee S. Sphingolipids in atherosclerosis and vascular biology. Arterioscler Thromb Vasc Biol 18 (1998) 1523-1533
10. Di Napoli M., and Papa F. Inflammation, hemostatic markers, and antithrombotic agents in relation to long-term risk of new cardiovascular events in first-ever ischemic stroke patients. Stroke 33 (2002) 1763-1771
11. Dirnagl U., Klehmet J., Braun J.S., Harms H., Meisel C., Ziemssen T., Prass K., and Meisel A. Stroke-induced immunodepression: experimental evidence and clinical relevance. Stroke 38 (2007) 770-773
12. Du X., Tang Y., Xu H., Lit L., Walker W., Ashwood P., Gregg J.P., and Sharp F.R. Genomic profiles for human peripheral blood T cells, B cells, natural killer cells, monocytes, and polymorphonuclear cells: comparisons to ischemic stroke, migraine, and Tourette syndrome. Genomics 87 (2006) 693-703
13. Endres M. Statins: potential new indications in inflammatory conditions. Atherosclerosis 7 (2006) 31-35
14. Fujita E., Kouroku Y., Miho Y., Tsukahara T., Ishiura S., and Momoi T. Wortmannin enhances activation of cpp32 (caspase-3) induced by TNF or anti-Fas. Cell Death Differ 5 (1998) 289-297
15. Garcia J.H., and Kamijyo Y. Cerebral infarction. Evolution of histopathological changes after occlusion of a middle cerebral artery in primates. J Neuropathol Exp Neurol 33 (1974) 408-421
16. Garlichs C.D., John S., Schmeisser A., Eskafi S., Stumpf C., Karl M., Goppelt-Struebe M., Schmieder R., and Daniel W.G. Upregulation of CD40 and CD40 ligand (CD154) in patients with moderate hypercholesterolemia. Circulation 104 (2001) 2395-2400
17. Greig N.H., Mattson M.P., Perry T., Chan S.L., Giordano T., Sambamurti K., Rogers J.T., Ovadia H., and Lahiri D.K. New therapeutic strategies and drug candidates for neurodegenerative diseases: P53 and TNF-alpha inhibitors, and GLP-1 receptor agonists. Ann N Y Acad Sci 1035 (2004) 290-315
18. Haeusler K.G., Schmidt W.U., Föhring F., Meisel C., Helms T., Jungehulsing G.J., Nolte C.H., Schmolke K., Wegner B., Meisel A., Dirnagl U., Villringer A., and Volk H.D. Cellular immunodepression preceding infectious complications after acute ischemic stroke in humans. Cerebrovasc Dis 25 (2008) 50-58
19. Hakkinen T., Karkola K., and Yla-Herttuala S. Macrophages, smooth muscle cells, endothelial cells, and T-cells express CD40 and CD40L in fatty streaks and more advanced human atherosclerotic lesions. Colocalization with epitopes of oxidized low-density lipoprotein, scavenger receptor, and CD16 (Fc gammaRIII). Virchows Arch 437 (2000) 396-405
20. Hallenbeck J.M. The many faces of tumor necrosis factor in stroke. Nat Med 8 (2002) 1363-1368
21. Holvoet P., Macy E., Landeloos M., Jones D., Jenny N.S., Van de Werf F., and Tracy R.P. Analytical performance and diagnostic accuracy of immunometric assays for the measurement of circulating oxidized LDL. Clin Chem 52 (2006) 760-764
22. Ishikawa M., Vowinkel T., Stokes K.Y., Arumugam T.V., Yilmaz G., Nanda A., and Granger D.N. CD40/CD40 ligand signaling in mouse cerebral microvasculature after focal ischemia/reperfusion. Circulation 111 (2005) 1690-1696
23. Iso H., Jacobs Jr. D.R., Wentworth D., Neaton J.D., and Cohen J.D. Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial. N Engl J Med 320 (1989) 904-910
24. Jeong Y.J., Choi Y.J., Kwon H.M., Kang S.W., Park H.S., Lee M., and Kang Y.H. Differential inhibition of oxidized LDL-induced apoptosis in human endothelial cells treated with different flavonoids. Br J Nutr 93 (2005) 581-591
25. Jovinge S., Ares M.P., Kallin B., and Nilsson J. Human monocytes/macrophages release TNF-alpha in response to ox-LDL. Arterioscler Thromb Vasc Biol 16 (1996) 1573-1579
26. Kinscherf R., Cafaltzis K., Röder F., Hildebrandt W., Deigner H.P., Breitkreutz R., Feussner G., Kreuzer J., Werle E., Michel G., Metz J., and Dröge W. Decrease of HDL-cholesterol levels linked to abnormal plasma thiol concentrations and thiol/disulfide redox state in hyperlipidemic subjects. Free Radic Biol Med 35 (2003) 1286-1292
27. Kinscherf R., Claus R., Wagner M., Gehrke C., Kamencic H., Hou D., Nauen O., Schmiedt W., Kovacs G., Pill J., Metz J., and Deigner H.P. Apoptosis caused by oxidized LDL is manganese superoxide dismutase and p53 dependent. FASEB J 12 (1998) 461-467
28. Kinscherf R., Deigner H.P., Usinger C., Pill J., Wagner M., Kamencic H., Hou D., Chen M., Schmiedt W., Schrader M., Kovacs G., Kato K., and Metz J. Induction of mitochondrial manganese superoxide dismutase in macrophages by oxidized LDL: its relevance in atherosclerosis of humans and heritable hyperlipidemic rabbits. FASEB J 11 (1997) 1317-1328
29. Kochanek P.M., and Hallenbeck J.M. Polymorphonuclear leukocytes and monocytes/macrophages in the pathogenesis of cerebral ischemia and stroke. Stroke 23 (1992) 1367-1379
30. Krupinski J., Kaluza J., Kumar P., and Kumar S. Immunocytochemical studies of cellular reaction in human ischemic brain stroke. Mab anti-CD68 stains macrophages, astrocytes and microglial cells in infarcted area. Folia Neuropathol 34 (1996) 17-24
31. Liu T., Clark R.K., McDonnell P.C., Young P.R., White R.F., Barone F.C., and Feuerstein G.Z. Tumor necrosis factor-alpha expression in ischemic neurons. Stroke 25 (1994) 1481-1488
32. Love S., B R., Srinivasan A., and Wilcock G.K. Activation of caspase-3 in permanent and transient brain ischaemia in man. Neuroreport 3 (2000) 2495-2499
33. Luo Y., Liang C., Xu C., Jia Q., Huang D., Chen L., Wang K., Wu Z., and Ge J. Ciglitazone inhibits oxidized-low density lipoprotein induced immune maturation of dendritic cells. J Cardiovasc Pharmacol 44 (2004) 381-385
34. + T cell apoptosis in patients with end-stage renal disease through Fas engagement. J Am Soc Nephrol 18 (2007) 331-342
35. Meisel C., Schwab J.M., Prass K., Meisel A., and Dirnagl U. Central nervous system injury-induced immune deficiency syndrome. Nat Rev 6 (2005) 775-786
36. Muller W.A., Weigl S.A., Deng X., and Phillips D.M. PECAM-1 is required for transendothelial migration of leukocytes. J Exp Med 178 (1993) 449-460
37. Offner H., Subramanian S., Parker S.M., Afentoulis M.E., Vandenbark A.A., and Hurn P.D. Experimental stroke induces massive, rapid activation of the peripheral immune system. J Cereb Blood Flow Metab 26 (2006) 654-665
38. Offner H., Vandenbark A.A., and Hurn P.D. Effect of experimental stroke on peripheral immunity: CNS ischemia induces profound immunosuppression. Neuroscience 158 (2009) 1098-1111
39. + T cell adhesion to endothelium. J Neuroimmunol 134 (2003) 166-178
40. Pasceri V., Cheng J.S., Willerson J.T., and Yeh E.T. Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs. Circulation 103 (2001) 2531-2534
41. Prass K., Braun J.S., Dirnagl U., Meisel C., and Meisel A. Stroke propagates bacterial aspiration to pneumonia in a model of cerebral ischemia. Stroke 37 (2006) 2607-2612
42. Prass K., Meisel C., Hoflich C., Braun J., Halle E., Wolf T., Ruscher K., Victorov I.V., Priller J., Dirnagl U., Volk H.D., and Meisel A. Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J Exp Med 198 (2003) 725-736
43. PSC Secretariat. Cholesterol, diastolic blood pressure, and stroke: 13 000 strokes in 450 000 people in 45 prospective cohorts. Lancet 346 (1995) 1647-1653
44. Qing Z., Sandor M., Radvany Z., Sewell D., Falus A., Potthoff D., Muller W.A., and Fabry Z. Inhibition of antigen-specific T cell trafficking into the central nervous system via blocking PECAM1/CD31 molecule. J Neuropathol Exp Neurol 60 (2001) 798-807
45. Schlittenhardt D., Schmiedt W., Bonaterra G.A., Metz J., and Kinscherf R. Colocalization of oxidized low-density lipoprotein, caspase-3, cyclooxygenase-2, and macrophage migration inhibitory factor in arteriosclerotic human carotid arteries. Cell Tissue Res 322 (2005) 425-435
46. Schulte-Herbruggen O., Klehmet J., Quarcoo D., Meisel C., and Meisel A. Mouse strains differ in their susceptibility to poststroke infections. Neuroimmunomodulation 13 (2006) 13-18
47. Schwab J.M., Seid K., and Schluesener H.J. Traumatic brain injury induces prolonged accumulation of cyclooxygenase-1 expressing microglia/brain macrophages in rats. J Neurotrauma 18 (2001) 881-890
48. Silvestrini M., Pietroiusti A., Magrini A., Matteis M., Carta S., Bernardi G., and Galante A. Leukocyte aggregation in patients with a previous cerebral ischemic event. Stroke 25 (1994) 1390-1392
49. Sörnäs R., Ostlund H., and Müller R. Cerebrospinal fluid cytology after stroke. Arch Neurol 26 (1972) 489-501
50. Sotgiu S., Zanda B., Marchetti B., Fois M.L., Arru G., Pes G.M., Salaris F.S., Arru A., Pirisi A., and Rosati G. Inflammatory biomarkers in blood of patients with acute brain ischemia. Eur J Neurol 13 (2006) 505-513
51. Tanne D., Haim M., Goldbourt U., Boyko V., Reshef T., Adler Y., Benderly M., Mekori Y.A., and Behar S. CD40 ligand and risk of ischemic stroke or coronary events in patients with chronic coronary heart disease. Int J Cardiol 107 (2006) 322-326
52. Thienel U., Loike J., and Yellin M.J. CD154 (CD40L) induces human endothelial cell chemokine production and migration of leukocyte subsets. Cell Immunol 198 (1999) 87-95
53. Uno M., Harada M., Takimoto O., Kitazato K.T., Suzue A., Yoneda K., Morita N., Itabe H., and Nagahiro S. Elevation of plasma oxidized LDL in acute stroke patients is associated with ischemic lesions depicted by DWI and predictive of infarct enlargement. Neurol Res 27 (2005) 94-102
54. Uno M., Kitazato K.T., Nishi K., Itabe H., and Nagahiro S. Raised plasma oxidised LDL in acute cerebral infarction. J Neurol Neurosurg Psychiatry 74 (2003) 312-316
55. Urbich C., Dernbach E., Aicher A., Zeiher A.M., and Dimmeler S. CD40 ligand inhibits endothelial cell migration by increasing production of endothelial reactive oxygen species. Circulation 106 (2002) 981-986
56. Urra X., Cervera A., Villamor N., Planas A.M., and Chamorro A. Harms and benefits of lymphocyte subpopulations in patients with acute stroke. Neuroscience 158 3 (2009) 1174-1183
57. Virag L. Structure and function of poly(adp-ribose) polymerase-1: role in oxidative stress-related pathologies. Curr Vasc Pharmacol 3 (2005) 209-214
58. Vogelgesang A., Grunwald U., Langner S., Jack R., Bröker B.M., Kessler C., and Dressel A. Analysis of lymphocyte subsets in patients with stroke and their influence on infection after stroke. Stroke 39 (2008) 237-241
59. Yin L., Ohtaki H., Nakamachi T., Dohi K., Iwai Y., Funahashi H., Makino R., and Shioda S. Expression of tumor necrosis factor alpha (TNFalpha) following transient cerebral ischemia. Acta Neurochir 86 (2003) 93-96